Browse Title Index
| Issue | Title | |
| Vol 55, No 5 (2024) | Changes in the nutritional status of children with cancer depending on clinical, demographic and social factors | Abstract PDF HTML |
| Anna Milaniuk, Katarzyna Drabko | ||
| Vol 54, No 1 (2023) | Changing risk factors in childhood acute lymphoblastic leukemia: experience from Kujawsko-Pomorski region 1976–2018 | Abstract PDF HTML |
| Joanna Stankiewicz, Ewa Demidowicz, Agnieszka Jatczak-Gaca, Natalia Bartoszewicz, Andrzej Kołtan, Sylwia Kołtan, Krzysztof Czyżewski, Monika Richert-Przygońska, Robert Dębski, Monika Pogorzała, Barbara Tejza, Piotr Księżniakiewicz, Joanna Cisek, Marlena Ewertowska, Agata Marjańska, Anna Dąbrowska, Anna Urbańczyk, Elżbieta Grześk, Kamila Jaremek, Eugenia Winogrodzka, Dominika Kołuda, Monika Łęcka, Monika Adamkiewicz, Sandra Wałach, Oliwia Grochowska, Sonia Tarasenko, Marta Mazalon, Magdalena Dziedzic, Małgorzata Kubicka, Beata Kuryło-Rafińska, Ewa Dembna, Agnieszka Majk, Mariusz Wysocki, Jan Styczyński | ||
| Vol 53, No 4 (2022) | Characteristics of COVID-19 in pediatric patients with hematological malignancies | Abstract PDF HTML |
| Olga Troyanovska, Olga Dorosh, Halyna Lytvyn, Iryna Tsymbalyuk, Oxana Vorobel, Olena Stepanyuk, Hrystyna Bodak, Olena Kozlova, Mariya Stasiv, Nata Basiv | ||
| Vol 54, No 3 (2023) | Characterization and prognostic factors of secondary to MDS/MPN and therapy-related AML: a single-center study | Abstract |
| Piotr Strzałka, Magdalena Czemerska, Kinga Michalina Krawiec, Sylwia Szydłowska, Damian Mikulski, Agnieszka Pluta, Agnieszka Wierzbowska | ||
| Vol 53, No 2 (2022) | Chemotherapy delays in children with acute lymphoblastic leukemia might influence the outcome of treatment | Abstract PDF HTML |
| Anna Puła, Maciej Zdunek, Kaja Michalczyk, Maciej Cichosz, Wojciech Młynarski | ||
| Vol 51, No 3 (2020) | Chimeric antigen receptor T in the treatment of multiple myeloma – state of the art and future directions | Abstract PDF |
| Dominik Dytfeld | ||
| Vol 53, No 2 (2022) | Chronic lymphocytic leukemia following venetoclax treatment failure | Abstract PDF HTML |
| Oktawia Sośnia, Bartosz Puła | ||
| Vol 44, No 2 (2013) | Chronic lymphocytic leukemia in older patients | Abstract PDF (Polish) |
| Tadeusz Robak | ||
| Vol 53, No 3 (2022) | Chronic myeloid leukemia: where do we stand, where can we go? | Abstract PDF HTML |
| Krzysztof Lewandowski, Jakub Lewandowski | ||
| Vol 46, No 2 (2015) | Chronic Myeloproliferative Neoplasms (Ph negative) – Polycythaemia Vera and Essential Thrombocythaemia; when hydroxycarbamide treatment proves ineffective | Abstract PDF (Polish) |
| Joanna Góra-Tybor | ||
| Vol 51, No 2 (2020) | Chronic use of PPIs as a potential cause of anemia: case reports and review of the literature | Abstract PDF |
| Martyna Podgajna, Michał Mielnik, Aneta Szudy-Szczyrek, Kinga Kuśmierczuk, Marek Hus | ||
| Vol 50, No 3 (2019) | Chłoniak z komórek płaszcza – rola terapii celowanych | Abstract PDF (Polish) |
| Wojciech Jurczak, Monika Długosz-Danecka | ||
| Vol 55, No 5 (2024) | Cladribine — still important in era of new therapies | Details XML PDF HTML |
| Bartosz Puła | ||
| Vol 53, No 1 (2022) | Class switch recombination defect in child with ataxia–telangiectasia with hyper IgM phenotype | Details PDF |
| Eman Gamal Baz, Mohamed Almalky, Tarek A. Abdelaziz | ||
| Vol 45, No 1 (2014) | Classification of barriers influencing compliance in patients with hematological cancer | Abstract PDF (Polish) |
| Anna Rychter, Joanna Góra-Tybor, Joanna Miniszewska | ||
| 91 - 105 of 729 Items | << < 2 3 4 5 6 7 8 9 10 11 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl
